Citadel Advisors »

Diamedica Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $74k 26k 2.84
2023-09-30 $43k 17k 2.58
2023-06-30 $65k 15k 4.32
2023-03-31 $67k 43k 1.53
2022-12-31 $65k 41k 1.58
2022-06-30 $0 18k 0.00
2022-03-31 $145k 58k 2.51
2021-12-31 $433k 116k 3.73
2021-09-30 $404k 105k 3.84
2021-06-30 $278k 62k 4.46
2021-03-31 $189k 21k 9.17